Normal and Pathologic Ejection Fraction Values
A normal ejection fraction is ≥50%, and an EF ≤40% is definitively pathologic, defining heart failure with reduced ejection fraction (HFrEF). 1
Classification Framework
The 2022 AHA/ACC/HFSA guidelines provide the authoritative classification system for EF 1:
Normal EF: ≥50%
- This represents preserved systolic function
- Patients with heart failure symptoms and EF ≥50% are classified as HFpEF (heart failure with preserved ejection fraction)
Mildly Reduced EF (HFmrEF): 41-49%
- This intermediate range represents a dynamic state
- Patients typically are either improving from HFrEF or deteriorating toward it
- One measurement is insufficient - you must track the trajectory over time
- These patients require additional objective evidence of cardiac dysfunction (elevated natriuretic peptides, evidence of increased LV filling pressures) to confirm heart failure diagnosis
Reduced EF (HFrEF): ≤40%
- This is definitively pathologic
- Most randomized controlled trials demonstrating survival benefit enrolled patients with EF ≤35% or ≤40%
- This threshold triggers guideline-directed medical therapy with proven mortality benefit
Refined Understanding from Population Data
Recent meta-analysis data provides more granular normal ranges 2:
- Lower limit of normal: approximately 52% for men and 53% for women
- Mean normal EF: 62.8% overall (61.9% men, 63.7% women)
- Critical threshold: An EF <50% has <5% probability of being within normal range across all demographic groups
- Asian populations show 2-3 percentage points higher values
Clinical implication: While guidelines use ≥50% as the HFpEF threshold, population data suggests that EF values of 50-52% in men or 50-53% in women warrant close monitoring, as they fall at the extreme lower boundary of normal.
Prognostic Significance
The "low-normal" range (50-55%) carries clinical importance 3:
- Asymptomatic individuals with EF 50-54% have 3.6-fold increased risk of developing heart failure over 10 years compared to those with EF ≥55%
- This risk is lower than those with EF <50% (9.5-fold increased risk) but still clinically significant
- However, low-normal EF does not increase mortality risk in asymptomatic patients
Common Pitfalls to Avoid
- Don't rely on single measurements in the 41-49% range - serial assessments are essential to determine trajectory
- Don't dismiss EF of 50-54% as completely normal - these patients need cardiovascular risk factor optimization and monitoring
- Don't assume normal EF excludes heart failure - HFpEF represents at least 50% of heart failure cases and is increasing in prevalence 1
- Don't forget that EF can vary by measurement technique - ensure consistency in follow-up assessments